Authors' response to a critical appraisal on "Assessing the cost-effectiveness of once-weekly somatrogon vs. daily somatropin for pediatric growth hormone deficiency".
Saved in:
| Title: | Authors' response to a critical appraisal on "Assessing the cost-effectiveness of once-weekly somatrogon vs. daily somatropin for pediatric growth hormone deficiency". |
|---|---|
| Authors: | Rivolo S; Modeling and Simulation, Evidera, Inc., Milan, Italy., Peter B; Modeling and Simulation, Evidera, Inc., Budapest, Hungary., Fahey M; Pfizer Healthcare, Dublin, Ireland., Kongnakorn T; Modeling and Simulation, Evidera, Bangkok, Thailand. |
| Source: | Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 1329-1331. Date of Electronic Publication: 2024 Nov 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1941-837X |
|---|---|
| DOI: | 10.1080/13696998.2024.2401282 |
